Nordicus Partners Corporation operates as publicly traded business accelerator and holding company for Nordic life sciences companies in the United States. The company focused on developing medicines supporting oral health. It also provides corporate finance activities, including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.
Show more...
FAQ
Nordicus Partners 今天的股价是多少?▼
NORDD 当前价格为 $9.08 USD,在过去 24 小时内下跌了 -9.2%。在图表上更密切关注 Nordicus Partners 股票的表现。
Nordicus Partners 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Nordicus Partners 的股票以代码 NORDD 进行交易。
Nordicus Partners 去年的营收是多少?▼
Nordicus Partners 去年的营收为 3,000USD。
Nordicus Partners 去年的净利润是多少?▼
NORDD 去年的净收益为 -298,000USD。
Nordicus Partners 会发放股息吗?▼
是的,NORDD 的股息每 zh 发放一次。每股最新股息为 9 USD。截至今日,股息率(FWD)% 为 0%。
Nordicus Partners 属于哪个行业?▼
Nordicus Partners从事于Consumer Discretionary行业。
Nordicus Partners 何时完成拆股?▼
Nordicus Partners 最近没有进行任何拆股。
Nordicus Partners 的总部在哪里?▼
Nordicus Partners 的总部位于 US 的 Beverly Hills。